Post hoc analyses showed significant reductions of mGluR5 (BPND) in the entorhinal cortex (34% reduction, p = 0.002) and parahippocampal gyrus (26% reduction, p = 0.012) of AD participants (Table 2, unpaired t test, uncorrected for multiple comparisons). This evidence concerns the gene GRM5 and Alzheimer disease.